Breast cancer detection based on cancer antigen 15-3; emphasis on optical and electrochemical methods: A review

被引:8
|
作者
Pourmadadi, Mehrab [1 ]
Ghaemi, Amirhossein [2 ]
Khanizadeh, Amirhossein [2 ]
Yazdian, Fatemeh [3 ]
Mollajavadi, Yasin [3 ]
Arshad, Rabia [4 ,5 ]
Rahdar, Abbas [6 ,7 ]
机构
[1] Shahid Beheshti Univ, Prot Res Ctr, Tehran 1983963113, GC, Iran
[2] Univ Tehran, Coll Engn, Sch Chem Engn, Dept Biotechnol, Tehran, Iran
[3] Univ Tehran, Fac New Sci & Technol, Dept Life Sci Engn, Tehran, Iran
[4] Univ Lahore, Fac Pharm, Lahore, Pakistan
[5] Univ Sci & Technol, Kampala, Uganda
[6] Univ Zabol, Fac Sci, Dept Phys, Zabol 53898615, Iran
[7] Univ Zabol, Key Lab Modeling & Simulat based Reliabil & Optimi, Zabol, Iran
来源
关键词
Breast cancer detection; Aptasensor; Optical biosensor; Electrochemical biosensor; Cancer antigen 15-3; BIOSENSORS; SURFACE; IMMOBILIZATION; NANOCOMPOSITE; NANOMATERIALS; LUMINESCENCE; STRATEGIES; MARKERS; TRENDS; CA-125;
D O I
10.1016/j.bios.2024.116425
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Cancer antigen 15 -3 (CA 15-3) is a crucial marker used in the diagnosis and monitoring of breast cancer (BC). The demand for early and precise cancer detection has grown, making the creation of biosensors that are highly sensitive and specific essential. This review paper provides a thorough examination of the progress made in optical and electrochemical biosensors for detecting the cancer biomarker CA 15-3. We focus on explaining their fundamental principles, sensitivity, specificity, and potential for point -of -care applications. The performance attributes of these biosensors are assessed by considering their limits of detection, reaction times, and operational stability, while also making comparisons to conventional methods of CA 15-3 detection. In addition, we explore the incorporation of nanomaterials and innovative transducer components to improve the performance of biosensors. This paper conducts a thorough examination of recent studies to identify the existing obstacles. It also suggests potential areas for future research in this fast progressing field.The paper provides insights into their advancement and utilization to enhance patient outcomes. Both categories of biosensors provide significant promise for the detection of CA 15-3 and offer distinct advantages compared to conventional analytical approaches.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Pretreatment values of serum CA 15-3 antigen related to prognostic factors in breast cancer patients
    Wojtacki, J
    DziewulskaBokiniec, A
    Kowalski, DM
    Zoltowska, A
    Ciesielski, D
    Suszko, M
    NEOPLASMA, 1996, 43 (04) : 225 - 229
  • [42] CA 15-3, ceruloplasmin and tissue polypeptide specific antigen as a tumour marker panel in breast cancer
    Özyilkan, Ö
    Baltali, E
    Kirazli, S
    EAST AFRICAN MEDICAL JOURNAL, 2000, 77 (06) : 291 - 294
  • [43] MUCIN-LIKE CANCER-ASSOCIATED ANTIGEN (MCA) COMPARED WITH CA 15-3 IN ADVANCED BREAST-CANCER
    STEGER, GG
    MADER, R
    DERFLER, K
    MOSER, K
    DITTRICH, C
    KLINISCHE WOCHENSCHRIFT, 1989, 67 (16): : 813 - 817
  • [44] Clinical value of CA 15-3 for detection of distant metastases in newly diagnosed breast cancer
    Gonssaud, Barbara
    Goussot, Vincent
    Berriolo-Riedinger, Alina
    Saitta-Aribau, Emeline
    Coutant, Charles
    Cochet, Alexandre
    Fumoleau, Pierre
    Riedinger, Jean-Marc
    ANNALES DE BIOLOGIE CLINIQUE, 2017, 75 (04) : 421 - 429
  • [45] Soluble factor of apoptotic signal versus cancer antigen 15-3 as a tumor marker in female Egyptian breast cancer patients
    Heiba, A. A.
    Taha, S. A.
    Kamal, S. M.
    IMMUNOLOGY, 2014, 143 : 181 - 181
  • [46] MUC1 568 A/G genotype-dependent Cancer Antigen 15-3 levels in breast cancer patients
    Kruit, Adrian
    Tilanus-Linthorst, Madeleine M.
    Boonstra, Joke G.
    van Schalk, Ron H. N.
    Grutters, Jan C.
    van den Bosch, Jules M. M.
    Ruven, Henk J. T.
    CLINICAL BIOCHEMISTRY, 2009, 42 (7-8) : 662 - 665
  • [47] Clinical value of CA 15-3 for early detection of relapse in locally advanced breast cancer
    Konan, Stephane
    Goussot, Vincent
    Desmoulins, Isabelle
    Lorgis, Veronique
    Coutant, Charles
    Fumoleau, Pierre
    Beltjens, Francoise
    Dalban, Cecile
    Lizard, Sarab
    Riedinger, Jean-Marc
    BULLETIN DU CANCER, 2015, 102 (10) : 834 - 844
  • [48] Ferrocenyl-doped silica nanoparticles as an immobilized affinity support for electrochemical immunoassay of cancer antigen 15-3
    Hong, Chenglin
    Yuan, Ruo
    Chai, Yaqin
    Zhuo, Ying
    ANALYTICA CHIMICA ACTA, 2009, 633 (02) : 244 - 249
  • [49] Combining the tumor abnormal protein test with tests for carcinoembryonic antigens, cancer antigen 15-3, and/or cancer antigen 125 significantly increased their diagnostic sensitivity for breast cancer
    Chen, Rui
    Jiang, Chaojun
    Zhu, Qiannan
    You, Sainan
    Li, Yan
    Li, Shuo
    Ding, Lei
    Meng, Haojie
    Yang, Yuxin
    Zha, Xiaoming
    Wang, Jue
    MEDICINE, 2020, 99 (29) : E21231
  • [50] COMPARISON OF BREAST-CANCER MUCIN (BCM) AND CA 15-3 IN HUMAN BREAST-CANCER
    GARCIA, MB
    BLANKENSTEIN, MA
    VANDERWALL, E
    NORTIER, JWR
    SCHORNAGEL, JH
    THIJSSEN, JHH
    BREAST CANCER RESEARCH AND TREATMENT, 1990, 17 (02) : 69 - 76